| Item Type | Name |
|
Academic Article
|
Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
|
|
Concept
|
Chromosomes, Human, Pair 18
|
|
Concept
|
Chromosomes, Human, Pair 12
|
|
Concept
|
Chromosomes, Human, Pair 16
|
|
Concept
|
Chromosome Banding
|
|
Concept
|
Chromosomes, Human, Pair 14
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Chromosomes, Human, Pair 3
|
|
Concept
|
Philadelphia Chromosome
|
|
Concept
|
Chromosomes, Human, Pair 5
|
|
Concept
|
Chromosomes, Human, Pair 21
|
|
Concept
|
Chromosomes, Human, Pair 8
|
|
Concept
|
Chromosome Mapping
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Chromosome Deletion
|
|
Concept
|
Chromosome Inversion
|
|
Concept
|
Chromosomes, Human, Pair 7
|
|
Concept
|
Chromosomes, Human, Pair 22
|
|
Academic Article
|
Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?
|
|
Academic Article
|
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
|
|
Academic Article
|
Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
|
|
Academic Article
|
Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
|
|
Academic Article
|
Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
|
|
Academic Article
|
Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
|
|
Academic Article
|
JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome.
|
|
Academic Article
|
Bone marrow transplant engraftment analysis with loss of an informative allele.
|
|
Academic Article
|
t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
|
|
Academic Article
|
The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
|
|
Academic Article
|
Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.
|
|
Academic Article
|
Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia.
|
|
Academic Article
|
Translocation (18;22)(q21;q11) in B-cell lymphomas: a report of 4 cases and review of the literature.
|
|
Academic Article
|
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
|
|
Academic Article
|
Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
|
|
Academic Article
|
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
|
|
Academic Article
|
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia.
|
|
Academic Article
|
inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
|
|
Academic Article
|
Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
|
|
Academic Article
|
High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis.
|
|
Academic Article
|
Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
|
|
Academic Article
|
Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
|
|
Academic Article
|
Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
|
|
Academic Article
|
Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
|
|
Academic Article
|
Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
|
|
Academic Article
|
Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24).
|
|
Academic Article
|
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
|
|
Academic Article
|
Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy.
|
|
Academic Article
|
CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
|
|
Academic Article
|
Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16).
|
|
Academic Article
|
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
|
|
Academic Article
|
Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
|
|
Academic Article
|
Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
|